Behavioral side effects and the family burden in children and adolescents with epilepsy receiving antiepileptic drugs
Recruiting
- Conditions
- G40Epilepsy
- Registration Number
- DRKS00031703
- Lead Sponsor
- niversitätsmedizin Halle Universitätsklinik und Poliklinik für Pädiatrie I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Children and adolescents with newly diagnosed epilepsy who require drug therapy to control seizures.
Exclusion Criteria
Taking other medications that have psychiatric disorders listed as a side effect.
Patients whose parent is not able to fill out the questionnaire independently (e.g. due to insufficient language skills).
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recording behavioral problems in children and adolescents with new-onset epilepsy using the German version of the standardized parent questionnaire Child Behavior Checklist” (CBCL) [Plück,Döpfner et al.] and monitoring how these develop under the respective drug therapy for seizure control. <br>The first survey takes place directly at the doctor's appointment after the epileptic seizure and before taking the antiepileptic medication for the first time. The second and third survey points take place approximately 6 weeks and 3 months after the start of drug therapy.
- Secondary Outcome Measures
Name Time Method Recording of predictors, which promote behaviorial side effects under therapy with antiepileptic drugs. The variables include the socioeconomic status of the families and the family burden of the childrens illness, which was measured using the shortened and the standardized version of the german verson of the Impact on Family Scale (FaBel) by Ravens-Sieberer et al. Furthermore added by exploratory questions. The socioeconomic status is determined immediately at the doctor's presentation after the epileptic seizure and before the first intake of antiepileptic medication. The family's burden of the child's illness is only assessed after 6 weeks and 3 months after the start of drug therapy.